Months after investment, Bayer strikes option deal with Dewpoint in CV, women’s health

November 14th, 2019 | Biocentury

Less than a year after Leaps by Bayer invested in biomolecular condensates company Dewpoint, the corporate VC’s parent company has struck an option deal that broadens its access to the start-up’s technology…

Full article